Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)
Cardiac C-Reactive Protein, Antigen, Antiserum, And Control. 510(k) K233242, from Siemens Healthcare Diagnostics, Inc. (Newark, DE). Product code NQD, class 2.
As of Nov 18, 2026, K233242 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Jan 18, 2024 after 112 days, with no recalls tied to it in FDA's recall database.
- Review time: 112 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2) assay is for in vitro diagnostic use in the quantitative determination of the concentration of C-Reactive Protein (CRP) in human serum and plasma (lithium heparin, sodium heparin or K2 EDTA) on the Atellica® CH Analyzer.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- CardioPhase® hsCRPK212559 · Siemens Healthcare Diagnostics Products GmbH · Dec 16, 2022
Other NQD clearances
The newest 510(k)s for the same product code; see every NQD device- Tina-quant Cardiac high sensitivity CRP IIIK260026 · Roche Diagnostics · Apr 2, 2026
- CardioPhase® hsCRPK212559 · Siemens Healthcare Diagnostics Products GmbH · Dec 16, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 28, 2023
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5270
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files